
Lyophilized vial
Retatrutide
Triple-agonist peptide studied at the GLP-1, GIP and glucagon receptors.
$105.00
Incretin and amylin-pathway research compounds.

Triple-agonist peptide studied at the GLP-1, GIP and glucagon receptors.

Long-acting GLP-1 receptor agonist analogue for metabolic pathway studies.

Dual GIP / GLP-1 receptor agonist for incretin-signalling research.


Pre-combined triple agonist and amylin analogue in a single vial.